The record → All 128 providers → NewSelf
Provider Dossier · newself.com · Last verified 11 November 2026
Is NewSelf legit?
Quick answerLast verified · GLP-1 Dossier Editorial Desk
Our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving NewSelf (newself.com), each linked to the original document below.
Published prices start at $99.97/mo, with medication included.
It supplies compounded GLP-1 medication, which is not FDA-approved.
Disclosure: Unmonetized direct link (NewSelf has no commercial relationship with this site).
Yes, NewSelf (newself.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving the company, each linked to the original government or court document below.
On the clinical side, NewSelf prescribes compounded GLP-1 medication only (prepared by a compounding pharmacy rather than an FDA-approved manufacturer), and its published plan starts at $99.97/mo (medication included).
Comparing NewSelf against compounded only providers with 0 actions on file
NewSelf has 1 regulatory or legal action documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:
- Website & Terms inspected
- newself.com (Direct checkout & Terms of Service verified)
- Last price & terms read
- 16 November 2026 (Medication included in quoted monthly rate)
- 503A / 503B pharmacy disclosure
- No partner compounding pharmacy named upfront before intake
- Public registries searched
- FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 1 primary document linked below
- Researcher field note
- Still compounded-only, with the disclosure that compounded drugs are not FDA-approved. Products are sold as Semaglutide+ and Tirzepatide+ with added vitamins; B12 and ondansetron are sold separately from $74/month.
What it actually supplies
Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025.
Named on its own site (newself.com): Semaglutide+, Tirzepatide+.
What regulators and courts have said
Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.
February 2026
FDA warning letter to NewSelf Limited alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the NewSelf name, representing it as the manufacturer when it was not, and because website claims such as "Same active ingredient as Ozempic & Wegovy" and references to "FDA-approved use" implied the compounded products had been FDA-approved.
Corporate entity, pricing & cancellation terms
Still compounded-only, with the disclosure that compounded drugs are not FDA-approved. Products are sold as Semaglutide+ and Tirzepatide+ with added vitamins; B12 and ondansetron are sold separately from $74/month.
Go direct
The button below is a plain direct link to NewSelf and earns us nothing. NewSelf has no commercial arrangement with this desk and is documented under the exact same verification rules as companies that do pay.
Visit NewSelf (newself.com) →Lower advertised starting prices
Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.
If you prefer FDA-approved medication only
These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Reference notes
NewSelf: key questions answered
- Is NewSelf (newself.com) legit or a scam? What does the public record show?
- Yes. NewSelf (newself.com) is an active, operating US weight-loss telehealth company. It supplies compounded semaglutide or tirzepatide prepared by a state-licensed compounding pharmacy rather than an FDA-approved brand-name drug. Our regulatory sweep matched 1 primary-sourced regulatory or legal action on file: FDA warning letter to NewSelf Limited alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the NewSelf name, representing it as the manufacturer when it was not, and because website claims such as "Same active ingredient as Ozempic & Wegovy" and references to "FDA-approved use" implied the compounded products had been FDA-approved.
- Does NewSelf sell compounded or FDA-approved weight loss medication?
- Compounded only. Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025. Specifically named on newself.com: Semaglutide+, Tirzepatide+.
- What are NewSelf weight loss pricing, hidden fees, and cancellation terms?
- NewSelf (newself.com) publishes weight-loss plans starting at $99.97 per month, with medication included in that monthly figure. Contract and billing terms: The site states there are no membership fees and no surprise charges, and advertises a free visit; per its homepage (read 11 Nov 2026) Semaglutide+ is “as low as” $99.97/mo ($134.99 month to month) and Tirzepatide+ “as low as” $144.49/mo ($224.99 month to month). Still compounded-only, with the disclosure that compounded drugs are not FDA-approved. Products are sold as Semaglutide+ and Tirzepatide+ with added vitamins; B12 and ondansetron are sold separately from $74/month.
- What compounding or fulfillment pharmacy does NewSelf use?
- NewSelf (newself.com) states that compounded GLP-1 prescriptions are fulfilled through state-licensed 503A or 503B compounding pharmacies, without listing specific partner pharmacy names on its public pre-checkout pages. Patients can verify the exact compounding pharmacy, address, and state board license number printed on the prescription vial label upon delivery.
- Are there FDA warning letters, lawsuits, or regulatory complaints against NewSelf?
- Yes. We hold 1 primary-sourced regulatory or legal action on record involving NewSelf (newself.com): FDA warning letter to NewSelf Limited alleging its compounded semaglutide and tirzepatide were misbranded because the labels bore the NewSelf name, representing it as the manufacturer when it was not, and because website claims such as "Same active ingredient as Ozempic & Wegovy" and references to "FDA-approved use" implied the compounded products had been FDA-approved. Every entry links directly to the primary FDA, NAD, or court document on this page.